Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell disease.
Saved in:
| Title: | Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell disease. |
|---|---|
| Authors: | Limerick E; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Hsieh M; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Queen J; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Grecco ML; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Varga J; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Brooks J; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Coles W; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Jeffries N; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Fitzhugh CD; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America. |
| Source: | PloS one [PLoS One] 2026 Mar 23; Vol. 21 (3), pp. e0332282. Date of Electronic Publication: 2026 Mar 23 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
